Related Experiment Video
Updated: Sep 9, 2025
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Thiazole derivatives in cancer therapy: mechanistic insights, bioactivity, and future perspective
Honey Saini1, Anuradha Mehra1, Amit Mittal1
1Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.
Abstract:
Globally, cancer is the primary cause of both mortality and morbidity. Many researchers are working to create new anticancer drugs that are less harmful and more effective. A thiazole scaffold is a great option for developing compounds that interact with cancer target locations and block the biological pathways causing the disease to spread. The current state of thiazole-based anticancer medicines is highlighted in this review, along with recent research findings. The thiazole moiety is an eccentric building block for creating anticancer medications. Thiazole derivatives have a great pharmacological profile that targets a variety of proteins and enzymes. The thiazoles are highlighted by the nitrogen atom's ability to establish hydrogen bonds with their targets. Thiazole has been shown in numerous clinical trials to be useful in treating cancer by acting through a variety of routes. Research on thiazole derivatives for cancer treatment featuring a superior pharmacokinetic profile is encouraged by the approval of thiazole-based medications for use as chemotherapeutics, such as Dasatinib and Ixazomib. This led to the consideration of thiazole derivatives as anticancer drugs to identify possible derivatives that are currently being investigated. This review covers research on thiazole scaffolds with anti-cancer potential both in vitro and in vivo that was published between 2020 and 2025.
Insights
Thiazole derivatives show promise as effective anticancer drugs, targeting cancer pathways with fewer side effects. Ongoing research focuses on optimizing their pharmacokinetic profiles for improved cancer treatment strategies.
Area of Science:
- Medicinal Chemistry
- Oncology
- Drug Discovery
Background:
- Cancer remains a leading global cause of mortality and morbidity.
- Developing novel, effective, and less toxic anticancer drugs is a critical research area.
- The thiazole scaffold is recognized for its potential in designing targeted anticancer agents.
Purpose of the Study:
- To review the current status of thiazole-based anticancer drugs.
- To highlight recent research findings on thiazole derivatives in cancer treatment.
- To explore thiazole scaffolds for their anti-cancer potential in vitro and in vivo.
Main Methods:
- Literature review of research published between 2020 and 2025.
- Analysis of thiazole derivatives' interaction with cancer targets.
- Evaluation of pharmacological profiles and pharmacokinetic properties.
Main Results:
- Thiazole derivatives exhibit a favorable pharmacological profile, targeting diverse proteins and enzymes.
- The nitrogen atom in thiazoles facilitates hydrogen bonding with biological targets.
- Clinical trials indicate thiazole-based compounds are effective in various cancer treatment routes.
Conclusions:
- Thiazole derivatives are versatile building blocks for anticancer drug development.
- The success of approved thiazole-based drugs like Dasatinib encourages further research.
- Thiazole scaffolds hold significant potential for novel chemotherapeutics with improved pharmacokinetic properties.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:10Drugs that Destabilize Microtubules
01:15Drugs that Stabilize Microtubules
02:34Inhibition of Cdk Activity
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...